2m 2m 2m 2m 2m 2m 2m
Uniqure (QURE)
NASDAQ
$48.73+$4.34 (+9.77%)
Price as of Jun 23, 2026 7:06 PM EDT- $2.4BMarket Cap
- 218.21%1-Year Change
- BiotechnologyIndustry
Uniqure (QURE)
$48.73+$4.34 (+9.77%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 15.9M -41.24% | 27.1M +71.17% | 15.8M -85.12% | 106.5M -79.68% | |
Cost of Revenue | 1.7M +33.07% | 1.3M +1,849.23% | 65,000 -94.82% | 1.3M -94.98% | |
Gross Profit | 14.2M -44.89% | 25.9M +63.85% | 15.8M -85.01% | 105.2M -78.91% | |
Sales and Marketing Expense | 65.5M +24.31% | 52.7M -29.41% | 74.6M +35.47% | 55.1M -2.19% | |
Research and Development Expense | -140.7M -2.16% | -143.8M -33.08% | -214.9M +8.74% | -197.6M +37.65% | |
Depreciation and Amortization Expense | 14.8M +490.36% | 2.5M +2,400.00% | 100,000 -98.83% | 8.5M +16.96% | |
Total Operating Expenses | 207.8M -3.24% | 214.8M -29.14% | 303.1M +18.40% | 256.0M +13.87% | |
Operating Profit | -185.3M +0.57% | -184.3M -34.85% | -282.9M +97.59% | -143.2M -146.09% | |
Interest Income | 17.0M -20.77% | 21.4M +9.47% | 19.6M +3,112.15% | 609,000 +275.93% | |
Interest Expense | -54.0M +6.51% | -50.7M +22.00% | -41.6M +255.07% | -11.7M +56.60% | |
Interest Income and Expense and Net | -37.0M +26.46% | -29.3M +33.14% | -22.0M +98.24% | -11.1M +51.74% | |
Total Nonoperating Income and Expense | 10.9M +295.11% | 2.8M 0.00% | 2.8M 0.00% | 2.8M +1,825.00% | |
Income before Taxes | -193.3M -18.47% | -237.1M -22.65% | -306.6M +139.01% | -128.3M -138.54% | |
Income Taxes | 5.6M +131.82% | 2.4M +26.44% | 1.9M +230.68% | -1.5M -145.69% | |
Extraordinary Items | N/A N/A | N/A N/A | 1.4M N/A | N/A N/A | |
Net Income | -199.0M -16.94% | -239.6M -22.34% | -308.5M +143.30% | -126.8M -138.47% | |
Net Income from Continuing Operations Applicable to Common | -193.3M -19.29% | -239.6M -22.34% | -308.5M +143.30% | -126.8M -138.47% | |
Basic EPS and Net Income | -3.46 -29.67% | -4.92 -23.96% | -6.47 +138.75% | -2.71 -137.80% | |
Diluted EPS and Net Income | -3.46 -29.67% | -4.92 -23.96% | -6.47 +138.75% | -2.71 -138.49% | |
Basic Weighted Average Shares | 57.5M +18.20% | 48.6M +2.05% | 47.7M +2.00% | 46.7M +1.63% | |
Diluted Weighted Average Shares | 57.5M +18.20% | 48.6M +2.05% | 47.7M +2.00% | 46.7M -0.23% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 80.2M -49.51% | 158.9M -34.15% | 241.4M +5.85% | 228.0M -59.01% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 80.2M -49.51% | 158.9M -34.15% | 241.4M +5.85% | 228.0M -59.01% | |
Total Current Assets | 656.0M +68.08% | 390.3M -40.13% | 651.9M +36.72% | 476.8M -24.11% | |
Accumulated Depreciation | 43.7M +38.16% | 31.7M -43.14% | 55.7M +26.17% | 44.1M +19.58% | |
Property and Plant and Equipment and Net | 13.8M -32.43% | 20.4M -56.12% | 46.5M -7.88% | 50.5M +16.15% | |
Total Long-Term Assets | 168.9M +1.61% | 166.2M -7.56% | 179.8M -21.19% | 228.2M +26.11% | |
Total Assets | 824.9M +48.22% | 556.5M -33.08% | 831.7M +17.98% | 705.0M -12.88% | |
Income Taxes Payable | 8.0M +13.12% | 7.0M -6.63% | 7.5M -8.65% | 8.3M -36.06% | |
Total Short-Term Debt | 50.0M 0.00% | 50.0M -50.00% | 100.0M 0.00% | 100.0M 0.00% | |
Total Current Liabilities | 62.9M +57.09% | 40.1M -45.64% | 73.7M -2.96% | 75.9M +106.51% | |
Total Long-Term Debt | 49.7M -3.17% | 51.3M -49.56% | 101.7M -1.01% | 102.8M +1.81% | |
Total Long-Term Liabilities | 563.1M +7.62% | 523.2M -4.93% | 550.3M +259.62% | 153.0M -13.36% | |
Total Liabilities | 626.0M +11.13% | 563.3M -9.73% | 624.0M +172.55% | 229.0M +7.29% | |
Retained Earnings | -1.3B +17.61% | -1.1B +26.90% | -890.4M +53.01% | -581.9M +27.86% | |
Total Stockholders Equity | 198.9M +3,045.81% | -6.8M -103.25% | 207.7M -56.37% | 476.0M -20.10% | |
Total Shares Outstanding | 62.3M +27.25% | 49.0M +2.41% | 47.8M +1.84% | 47.0M +1.45% | |
Cash Flow | |||||
Cash from Operating Activities | -178.0M -2.61% | -182.7M +25.22% | -145.9M +0.60% | -145.1M -150.38% | |
Capital Expenditures | 439,000 -86.97% | 3.4M -52.92% | 7.2M -59.55% | 17.7M +1.43% | |
Cash from Investing Activities | -321.6M -297.35% | 163.0M +179.23% | -205.7M +12.56% | -182.7M +171.17% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 415.4M +798.31% | -59.5M -116.40% | 362.7M +25,001.80% | 1.4M -98.48% | |
Financials Ratio | |||||
Gross Margin | 89.42% -6.20% | 95.33% -4.28% | 99.59% +0.78% | 98.82% +3.77% | |
Operating Margin | -1,163.23% +71.17% | -679.58% -61.94% | -1,785.46% +1,228.04% | -134.44% -326.80% | |
Return on Assets | -28.81% -16.53% | -34.51% -14.04% | -40.15% +139.74% | -16.75% -129.21% | |
Return on Equity | -207.10% -13.15% | -238.46% +164.25% | -90.24% +281.42% | -23.66% -130.14% | |
Revenue Growth | -41.24% -157.95% | 71.17% +183.61% | -85.12% +6.83% | -79.68% -106.14% | |
Current Ratio | 10.43 +6.99% | 9.74 +10.13% | 8.85 +40.89% | 6.28 -63.25% | |
Cash Ratio | 1.28 -67.86% | 3.97 +21.12% | 3.28 +9.08% | 3.00 -80.15% | |
Debt-to-Equity Ratio | 0.50 +103.34% | -15.01 -1,644.67% | 0.97 +128.05% | 0.43 +26.30% | |
Debt-to-Assets Ratio | 0.12 -33.61% | 0.18 -24.94% | 0.24 -15.68% | 0.29 +15.82% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow